Carzenide

Carzenide

SCHEMBL312419

NS(=O)(=O)c1ccc(C(=O)O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 14/20 1.00
CA1 P00915 12/20 1.00
CA9 Q16790 11/20 1.00
CA12 O43570 8/20 1.00
CA14 Q9ULX7 8/20 1.00
CA5A P35218 3/20 1.00
CA5B Q9Y2D0 3/20 1.00
CA3 P07451 2/20 1.00
CA6 P23280 2/20 1.00
CA7 P43166 2/20 1.00
CYP2C19 P33261 1/20 1.00
CA4 P22748 2/20 0.70
CA13 Q8N1Q1 1/20 0.70
MAOA P21397 1/20 0.60
TP53 P04637 1/20 0.57
TSHR P16473 1/20 0.57
F2 P00734 1/20 0.57
PRSS1 P07477 1/20 0.57
PRSS2 P07478 1/20 0.57
PRSS3 P35030 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carzenide SCHEMBL27794163 0.98 CA2 (0.95) CA2CA1CA9CA12CA14
Carzenide SCHEMBL3872466 0.98 CA2 (0.95) CA2CA1CA9CA12CA14
SCHEMBL1874815 0.94 CA2 (1.00) CA2CA1CA9CA12CA14
Sulfanilamide SCHEMBL9076735 0.92 CA2 (0.84) CA2CA1CA9CA12CA14
SCHEMBL8012545 0.88 CA2 (0.78) CA2CA1CA9CA12CA14
SCHEMBL29164152 0.88 CA2 (0.78) CA2CA1CA9CA12CA14
Carzenide SCHEMBL28559388 0.87 CA2 (0.75) CA2CA1CA9CA12CA14
Carzenide SCHEMBL28162766 0.85 CA2 (0.72) CA2CA1CA9CA12CA14
Carzenide SCHEMBL6855368 0.85 CA2 (0.78) CA2CA1CA9CA12CA14
Sulfanilamide SCHEMBL28647643 0.84 CA1 (0.71) CA2CA1CA9CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1880 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026102972-A1 PALLADIUM-PLATED/GOLD-PALLADIUM-PLATED COPPER BONDING WIRE WITH HIGH CORROSION RESISTANCE AND HIGH CONDUCTIVITY, AND PRODUCTION PROCESS THEREFOR 上海万生合金材料有限公司 2026-05-21 WO claimed
EP-4132503-B1 PROBENECID FOR USE IN THE TREATMENT OF SARS-CO-V2 INFECTIONS UNIV GEORGIA (US) 2026-04-22 EP claimed
EP-4127157-B1 MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS ENCODIA INC (US) 2026-02-11 EP claimed
CN-116656120-B Polyamide master batch and preparation method and application thereof 金发科技股份有限公司 2025-06-24 CN claimed
CN-120131678-A Antitumor N-acetyl-D-glucosamine-containing composition and preparation method thereof 辽宁泰阳医药科技开发有限公司 2025-06-13 CN claimed
CN-119838435-B Composite reverse osmosis membrane and preparation method thereof 湖南沁森高科新材料有限公司 2025-05-23 CN claimed
CN-119838435-A Composite reverse osmosis membrane and preparation method thereof 湖南沁森高科新材料有限公司 2025-04-18 CN claimed
CN-119153426-B High corrosion resistance high conductivity palladium plating/gold plating palladium copper bonding wire and production process thereof 上海万生合金材料有限公司 2025-04-11 CN claimed
CN-119061699-B Breathable water-based microfiber leather and manufacturing process thereof 福建极利新材料科技有限公司 2025-02-25 CN claimed
CN-119361331-A Layered porous carbon, preparation method thereof and supercapacitor 中国科学院赣江创新研究院 2025-01-24 CN claimed
WO-2001000029-A1 N-CHLOROSULFAMATE COMPOSITIONS HAVING ENHANCED ANTIMICROBIAL EFFICACY S. C. JOHNSON & SON, INC. (US) 2001-01-04 WO claimed
US-5591752-A LEUKOTRIENE ANTAGONIST, ANTIALLERGEN, ANTIINFLAMMATORY AGENT, DIBENZ(B,E)OXEPINE UBE INDUSTRIES, LTD. (JP) 1997-01-07 US claimed
US-5480760-A SULFONAMIDE THERMAL SOLVENT FOR IMPROVED DIFFUSION TRANSFER EASTMAN KODAK COMPANY (US) 1996-01-02 US claimed
EP-0685478-A1 QUINOLINE DERIVATIVE UBE INDUSTRIES, LTD. (JP) 1995-12-06 EP claimed
US-5403750-A Polyetherurethanes modified with amine, mercpto or hydroxyl functional groups W. R. GRACE & CO.-CONN. (US) 1995-04-04 US claimed
EP-0036351-B1 OPHTHALMIC COMPOSITIONS OF CARBONIC ANHYDRASE INHIBITORS FOR TOPICAL APPLICATION IN THE TREATMENT OF ELEVATED INTRAOCULAR PRESSURE MERCK & CO. INC. (US) 1985-01-02 EP claimed
EP-0014642-B1 OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF CARBONIC ANHYDRASE INHIBITORS AND S-(-)-1-(TERT-BUTYLAMINO)-3-(4-MORPHOLINO-1,2,5-THIADIAZOL-3-YL)-OXY-2-PROPANOL FOR TOPICAL APPLICATION IN THE TREATMENT OF ELEVATED INTRAOCULAR PRESSURE MERCK & CO. INC. (US) 1984-03-21 EP claimed
EP-0036351-A2 Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure MERCK & CO. INC. (US) 1981-09-23 EP claimed
EP-0033042-A1 Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors MERCK & CO. INC. (US) 1981-08-05 EP claimed
EP-0014642-A2 Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitors and S-(-)-1-(tert-butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yl)-oxy-2-propanol for topical application in the treatment of elevated intraocular pressure MERCK & CO. INC. (US) 1980-08-20 EP claimed